Education
About Us
Working with TipRanks
Follow Us
Australian Clinical Labs Ltd (AU:ACL)
ASX:ACL
RESEARCH TOOLSreports
Total Valuation
Australian Clinical Labs Ltd has a market cap or net worth of AU$536.15M. The enterprise value is AU$834.50M.
Market CapAU$536.15M
Enterprise ValueAU$834.50M
Share Statistics
Australian Clinical Labs Ltd has 196,391,390 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding196,391,390
Owned by Insiders<0.01%
Owned by Institutions―
Financial Efficiency
Australian Clinical Labs Ltd’s return on equity (ROE) is 0.13 and return on invested capital (ROIC) is 7.74%.
Return on Equity (ROE)0.13
Return on Assets (ROA)0.04
Return on Invested Capital (ROIC)7.74%
Return on Capital Employed (ROCE)0.15
Revenue Per Employee140.76K
Profits Per Employee4.88K
Employee Count4,900
Asset Turnover1.16
Inventory Turnover26.29
Valuation Ratios
The current PE Ratio of Australian Clinical Labs Ltd is 20.86. Australian Clinical Labs Ltd’s PEG ratio is 0.73.
PE Ratio20.86
PS Ratio0.00
PB Ratio3.31
Price to Fair Value2.81
Price to FCF3.37
Price to Operating Cash Flow3.35
PEG Ratio0.73
Income Statement
In the last 12 months, Australian Clinical Labs Ltd had revenue of 689.73M and earned 23.93M in profits. Earnings per share was 0.12.
Revenue689.73M
Gross Profit247.36M
Operating Income56.91M
Pretax Income36.37M
Net Income23.93M
EBITDA169.65M
Earnings Per Share (EPS)0.12
Cash Flow
In the last 12 months, operating cash flow was 167.16M and capital expenditures -6.68M, giving a free cash flow of 160.47M billion.
Operating Cash Flow167.16M
Free Cash Flow160.47M
Free Cash Flow per Share0.82
Dividends & Yields
Australian Clinical Labs Ltd pays an annual dividend of AU$0.125, resulting in a dividend yield of 2.56%
Dividend Per ShareAU$0.125
Dividend Yield2.56%
Payout Ratio54.22%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.84
52-Week Price Change12.35%
50-Day Moving Average2.98
200-Day Moving Average3.31
Relative Strength Index (RSI)34.20
Average Volume (3m)991.32K
Important Dates
Australian Clinical Labs Ltd upcoming earnings date is Aug 20, 2025, TBA Not Confirmed.
Last Earnings DateFeb 25, 2025
Next Earnings DateAug 20, 2025
Ex-Dividend DateMar 27, 2025
Financial Position
Australian Clinical Labs Ltd as a current ratio of 0.64, with Debt / Equity ratio of 186.89%
Current Ratio0.64
Quick Ratio0.56
Debt to Market Cap0.11
Net Debt to EBITDA1.67
Interest Coverage Ratio3.34
Taxes
In the past 12 months, Australian Clinical Labs Ltd has paid 12.12M in taxes.
Income Tax12.12M
Effective Tax Rate0.33
Enterprise Valuation
Australian Clinical Labs Ltd EV to EBITDA ratio is 4.61, with an EV/FCF ratio of 5.11.
EV to Sales1.13
EV to EBITDA4.61
EV to Free Cash Flow5.11
EV to Operating Cash Flow4.90
Balance Sheet
Australian Clinical Labs Ltd has AU$21.57M in cash and marketable securities with AU$315.32M in debt, giving a net cash position of AU$293.75M billion.
Cash & Marketable SecuritiesAU$21.57M
Total DebtAU$315.32M
Net CashAU$293.75M
Net Cash Per ShareAU$1.50
Tangible Book Value Per ShareAU$0.06
Margins
Gross margin is 36.49%, with operating margin of 8.25%, and net profit margin of 3.47%.
Gross Margin36.49%
Operating Margin8.25%
Pretax Margin5.27%
Net Profit Margin3.47%
EBITDA Margin24.60%
EBIT Margin5.98%
Analyst Forecast
The average price target for Australian Clinical Labs Ltd is AU$3.30, which is 11.43% higher than the current price. The consensus rating is Hold
Price TargetAU$3.30
Price Target Upside20.88% Upside
Analyst ConsensusHold
Analyst Count1
Revenue Growth Forecast7.80%
EPS Growth Forecast99.87%